Nomura Holdings
EPZM

Nomura Holdings’s Epizyme, Inc EPZM Stock Holding History

Nomura Holdings’s Portfolio EPZM Stock Details EPZM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-203,197
Closed -$509K – 2639
2021
Q4 		$509K Buy
+203,197
New +$798K ﹤0.01% 1479
2021
Q2 		– Sell
-22,250
Closed -$193K – 2521
2021
Q1 		$193K Buy
22,250
+8,250
+59% +$85.4K ﹤0.01% 1645
2020
Q4 		$153K Buy
+14,000
New +$173K ﹤0.01% 1398

Other funds holding EPZM

RM
RP Management New York $139M AUM 37.98% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Nomura Holdings's EPZM Position: Q1 2022 in Review

Nomura Holdings sold out of Epizyme, Inc (EPZM) in Q1 2022, closing a stake of 203,197 shares — an estimated $509K sold.

Nomura Holdings first reported a position in EPZM in Q4 2020 and held it in 3 quarters. The position peaked at $509K in Q4 2021. 120 funds tracked by Wall St. Rank hold EPZM as of Q1 2022.

  • Nomura Holdings reported no remaining Epizyme, Inc position as of Q1 2022 after selling out during the quarter.
  • Nomura Holdings sold 203,197 Epizyme, Inc shares in Q1 2022, an estimated $509K.
  • Nomura Holdings first reported a position in Epizyme, Inc in Q4 2020 and held it in 3 quarters.
  • Nomura Holdings's Epizyme, Inc position peaked at $509K in Q4 2021.
  • 120 funds tracked by Wall St. Rank held Epizyme, Inc as of Q1 2022.

Based on Nomura Holdings's 13F filing for Q1 2022, filed 18 May 2022.